Bristol-Myers Squibb Presents New 4-Year Data from the Long-Term Extensions of …MarketWatch (press release)Results showed that the safety profile of NULOJIX through year 4 was consistent compared with results at year 3 with no new safety signals bein…
Bristol-Myers Squibb Presents New 4-Year Data from the Long-Term Extensions of the BENEFIT and BENEFIT-EXT Clinical …
Bristol-Myers Squibb Company today announced new 4-year results from the long-term extensions of the BENEFIT and BENEFIT-EXT clinical trials of NULOJIX® , the first selective T-cell costimulation blocker indicated for the prophylaxis of organ rejectio…
Acetaminophen overdoses common cause of kids' liver failure – CBC.ca
CBC.caAcetaminophen overdoses common cause of kids' liver failureCBC.caAcetaminophen painkiller overdoses can cause life-threatening liver failure in children but the problem is avoidable, Canadian doctors say. "Acetaminophen overdose is a maj…
SymBio Announces Results Presented at ASCO 2012 Evaluating Clinical Benefits … – SYS-CON Media (press release)
SymBio Announces Results Presented at ASCO 2012 Evaluating Clinical Benefits …SYS-CON Media (press release)Come to New York and get yourself up to date with the Big Data revolution! As advanced data storage, access and analytics technologies aimed at…
SymBio Announces Results Presented at ASCO 2012 Evaluating … – Marketwire (press release)
SymBio Announces Results Presented at ASCO 2012 Evaluating …Marketwire (press release)SymBio Announces Results Presented at ASCO 2012 Evaluating Clinical Benefits of TREAKISYM® (Bendamustine) in Combination With Rituximab in Patients …
SymBio Announces Results Presented at ASCO 2012 Evaluating Clinical Benefits … – MarketWatch (press release)
SymBio Announces Results Presented at ASCO 2012 Evaluating Clinical Benefits …MarketWatch (press release)TOKYO, Jun 04, 2012 (MARKETWIRE via COMTEX) — SymBio Pharmaceuticals Limited (jasdaq:4582) announced today that results from a multicenter, Phas…
Pharmacyclics® Announces Updated Results for BTK Inhibitor Ibrutinib (PCI … – MarketWatch (press release)
Pharmacyclics® Announces Updated Results for BTK Inhibitor Ibrutinib (PCI …MarketWatch (press release)Abstract # 6515: Combination of the Bruton's tyrosine kinase inhibitor PCI-32765 with bendamustine/rituximab (BR) in patients with relapsed/ref…
What's Going Around: Chigger Bites – The Charlottesville Newsplex
What's Going Around: Chigger BitesThe Charlottesville NewsplexThey include: washing vigorously with soap and water, which removes the chigger, use over the counter steroid creams like hydrocortisone or calamine lotion, which can help with itching. …
One-Year Outcomes Not Worse in Obese Kidney Donors – Renal and Urology News
One-Year Outcomes Not Worse in Obese Kidney DonorsRenal and Urology NewsBOSTON—Researchers who examined renal outcomes in obese living kidney donors observed no increased incidence of hypertension, proteinuria, or renal dysfunction compared with non-…
Kinanis LLC Organizes Voluntary Blood Donation – Houston Chronicle
Kinanis LLC Organizes Voluntary Blood DonationHouston ChronicleThe Law Firm Kinanis LLC organized a voluntary blood donation event which took place on the 17th May 2012 at the premises of Akamantis Conference and Exhibition Centre located in Nicosia, C…